In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 52

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_CUMM-8-1_002

تاریخ نمایه سازی: 11 آذر 1402

چکیده مقاله:

Background and Purpose: Oral candidiasis has become a growing problem in hospitals worldwide, and the development of antifungal drug resistance in Candida species constitutes a serious concern. This study aimed to evaluate the in vitro efficacy of nystatin, and micafungin with chlorhexidine against fluconazole-resistant and fluconazole-sensitive Candida albicans (C. albicans) isolates.Materials and Methods: In this experimental-laboratory study, a total of ۲۰fluconazole-resistant (n=۱۰) and fluconazole-susceptible (n=۱۰) C. albicans strains were obtained from the reference culture collection of the Invasive Fungi Research Center in Mazandaran University of Medical Sciences, Sari, Iran. In vitro combination of nystatin and micafungin with chlorhexidine was performed using a microdilution checkerboar method based on the Clinical and Laboratory Standards Institute guideline.Results: Micafungin had the highest antifungal activity against C. albicans susceptible and resistant strains, with a Geometric mean of (GM) =۰.۰۰۸µg/ml and GM=۰.۰۰۸µg/ml, followed by nystatin with GM=۰.۰۶µg/ml and GM=۰.۰۴۲µg/ml and chlorhexidine with GM=۰.۲۵µg/ml and GM=۰.۱۶۵µg/ml against C. albicans resistant and sensitive strains, respectively. The interaction of micafungin and nystatin withchlorhexidine showed a synergistic interaction against most C. albicans strains. Inaddition, no antagonistic interaction was observed between micafungin, nystatin, and chlorhexidine against C. albicans strains.Conclusion: The synergistic interaction of micafungin with chlorhexidine against azoleresistant C. albicans suggests an alternative approach to overcome antifungal drug resistance. However, further studies are needed for in vivo evaluation. Candida albicans, Chlorhexidine, Combination, Fluconazole, Micafungin,Nystatin

نویسندگان

Maede Salehi

Department of Oral Medicine, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran

Ali Malekzadeh Shafaroudi

Student Research Committee, School of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran

Maryam Daryani

Student Research Committee, School of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran

Alireza Khalilian

Department of Community Medicine, School of Medicine, Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, Iran

Fatemeh Ahangarkani

Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Tahere Molania

Department of Oral Medicine, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Ahmed A, Azim A, Baronia AK, Marak KRSK, Gurjar M. ...
  • Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA,Bandeira ...
  • Delaloye J, Calandra T. Invasive candidiasis as a cause of ...
  • Arendrup MC, Perlin DS. Echinocandin resistance: an emerging clinical problem? ...
  • Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. ...
  • Emara M, Ahmad S, Khan Z, Joseph L, Al-Obaid I, ...
  • Tavanti A, Davidson AD, Gow NAR, Maiden MCJ, Odds FC. ...
  • Correia A, Sampaio P, James S, Pais C. Candida bracarensis ...
  • Ahangarkani F, Badali H, Rezai MS, Shokohi T, Abtahian Z, ...
  • Aslani N, Janbabaei G, Abastabar M, Meis JF, Babaeian M, ...
  • Ahangarkani F, Shokohi T, Rezai MS, Ilkit M, Mahmoodi Nesheli ...
  • Abastabar M, Haghani I, Ahangarkani F, Rezai MS, Taghizadeh Armaki ...
  • Desnos-Ollivier M, Ragon M, Robert V, Raoux D, Gantier J-C, ...
  • Stuart MC, Kouimtzi M, Hill SR. WHO model formulary ۲۰۰۸. ...
  • Brookes ZLS, Bescos R, Belfield LA, Ali K, Roberts A. ...
  • Odds FC. Synergy, antagonism, and what the chequerboard puts between ...
  • Scheibler E, Garcia MCR, Medina da Silva R, Figueiredo MA, ...
  • Monteiro DR, Silva S, Negri M, Gorup LF, de Camargo ...
  • Alvendal C, Mohanty S, Bohm-Starke N, Brauner A. Antibiofilm activity ...
  • Garcia-Cuesta C, Sarrion-Pérez M-G, Bagán J V. Current treatment of ...
  • Monalis H, Sujith R, Leela KV, Balamurali V. Antibiotics in ...
  • Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. ...
  • Demir KK, Butler Laporte G, Del Corpo O, Ekmekjian T, ...
  • Baddley JW, Pappas PG. Combination antifungal therapy for the treatment ...
  • Campitelli M, Zeineddine N, Samaha G, Maslak S. Combination antifungal ...
  • Cui J, Ren B, Tong Y, Dai H, Zhang L. ...
  • Chen Y-L, Lehman VN, Averette AF, Perfect JR, Heitman J. ...
  • Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA,Ghannoum ...
  • Alastruey-Izquierdo A, Melhem MSC, Bonfietti LX, RodriguezTudela JL. Susceptibility test ...
  • نمایش کامل مراجع